Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non‐Hodgkin's Lymphoma

INTRODUCTION. To reduce health care costs and improve care, payers and physician groups are switching to quality‐based and episodic or bundled‐care models. Disease progression and associated costs may affect these models, particularly if such programs do not account for differences in disease severi...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncologist
Huvudupphovsmän: Reyes, Carolina, Engel‐Nitz, Nicole M., DaCosta Byfield, Stacey, Ravelo, Arliene, Ogale, Sarika, Bancroft, Tim, Anderson, Amy, Chen, May, Matasar, Matthew
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley & Sons, Inc. 2019
Ämnen:
Health Outcomes and Economics of Cancer Care
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6738303/
https://ncbi.nlm.nih.gov/pubmed/30808814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0019
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk